"Pandemic influenza poses a tremendous threat to the United States and to the world, with the potential to impact not only the health of the population, but society overall. Antivirals are one of several measures to control the impact of pandemic influenza, and their use must be balanced with other countermeasure and containment options. The Department of Health and Human Services' (HHS) Pandemic Influenza Plan, released in November 2005, calls for stockpiling antivirals to treat 25% of the U.S. population during a pandemic - approximately 81 million treatment courses. This represents a significant investment of resources, including time and money, at both the state and federal levels. The current antiviral stockpiling proposal, announced by the federal government in early 2006, is a joint activity primarily between the states and the federal government, with the federal government purchasing a total of 50 million doses and the states purchasing up to 31 million doses at a subsidized price through federally-negotiated contracts with two drug manufacturers. This countermeasure must be managed and used in the most efficient and equitable manner to ensure maximum impact."
2006 Association of State and Territorial Health Officials (ASTHO). Posted here from Lessons Learned Information Sharing database (LLIS). Documents are for personal use only and copyright laws apply.
Lessons Learned Information Sharing (LLIS)